Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy.
Saved in:
| Title: | Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy. |
|---|---|
| Authors: | Davis-Porada J; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY, USA., Tozlu C; Department of Radiology, Weill Cornell Medicine, New York, NY, USA., Aiello C; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY, USA., Apostolidis SA; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Bove R; UCSF Weill Institute for Neuroscience, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Espinoza DA; Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ferreira Brito S; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA., Jacobs D; Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Kakara M; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA., Onomichi K; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA., Ricci A; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA., Sabatino JJ Jr; UCSF Weill Institute for Neuroscience, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Walker E; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Wherry EJ; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Zhang L; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Zhu W; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., Xia Z; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA., De Jager P; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA., Wesley SF; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA. sfw2116@cumc.columbia.edu., Straus Farber R; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA. rs3648@cumc.columbia.edu., Farber DL; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. df2396@cumc.columbia.edu.; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA. df2396@cumc.columbia.edu. |
| Source: | NPJ vaccines [NPJ Vaccines] 2025 May 17; Vol. 10 (1), pp. 98. Date of Electronic Publication: 2025 May 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40382362 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Davis-Porada+J%22">Davis-Porada J</searchLink>; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tozlu+C%22">Tozlu C</searchLink>; Department of Radiology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Aiello+C%22">Aiello C</searchLink>; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Apostolidis+SA%22">Apostolidis SA</searchLink>; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Division of Rheumatology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bar-Or+A%22">Bar-Or A</searchLink>; Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bove+R%22">Bove R</searchLink>; UCSF Weill Institute for Neuroscience, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Espinoza+DA%22">Espinoza DA</searchLink>; Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ferreira+Brito+S%22">Ferreira Brito S</searchLink>; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jacobs+D%22">Jacobs D</searchLink>; Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kakara+M%22">Kakara M</searchLink>; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Onomichi+K%22">Onomichi K</searchLink>; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ricci+A%22">Ricci A</searchLink>; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sabatino+JJ+Jr%22">Sabatino JJ Jr</searchLink>; UCSF Weill Institute for Neuroscience, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Walker+E%22">Walker E</searchLink>; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Wherry+EJ%22">Wherry EJ</searchLink>; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+W%22">Zhu W</searchLink>; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Xia+Z%22">Xia Z</searchLink>; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22De+Jager+P%22">De Jager P</searchLink>; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wesley+SF%22">Wesley SF</searchLink>; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA. sfw2116@cumc.columbia.edu.<br /><searchLink fieldCode="AU" term="%22Straus+Farber+R%22">Straus Farber R</searchLink>; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Neurology, Columbia Multiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, New York, NY, USA. rs3648@cumc.columbia.edu.<br /><searchLink fieldCode="AU" term="%22Farber+DL%22">Farber DL</searchLink>; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. df2396@cumc.columbia.edu.; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA. df2396@cumc.columbia.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2025 May 17; Vol. 10 (1), pp. 98. <i>Date of Electronic Publication: </i>2025 May 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40382362 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41541-025-01151-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 98 Titles: – TitleFull: Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Davis-Porada J – PersonEntity: Name: NameFull: Tozlu C – PersonEntity: Name: NameFull: Aiello C – PersonEntity: Name: NameFull: Apostolidis SA – PersonEntity: Name: NameFull: Bar-Or A – PersonEntity: Name: NameFull: Bove R – PersonEntity: Name: NameFull: Espinoza DA – PersonEntity: Name: NameFull: Ferreira Brito S – PersonEntity: Name: NameFull: Jacobs D – PersonEntity: Name: NameFull: Kakara M – PersonEntity: Name: NameFull: Onomichi K – PersonEntity: Name: NameFull: Ricci A – PersonEntity: Name: NameFull: Sabatino JJ Jr – PersonEntity: Name: NameFull: Walker E – PersonEntity: Name: NameFull: Wherry EJ – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Zhu W – PersonEntity: Name: NameFull: Xia Z – PersonEntity: Name: NameFull: De Jager P – PersonEntity: Name: NameFull: Wesley SF – PersonEntity: Name: NameFull: Straus Farber R – PersonEntity: Name: NameFull: Farber DL IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 05 Text: 2025 May 17 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2059-0105 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: NPJ vaccines Type: main |
| ResultId | 1 |